CAS 869185-85-3

SB 203580 hydrochloride

CAS: 869185-85-3

SB 203580 hydrochloride

Reinheit: ≥95%

Molekulargewicht: 413.9g/mol

Ref: 54-BUP10732

SB-203580 Hydrochloride

CAS: 869185-85-3

SB-203580 Hydrochloride

Molekulargewicht: 413.90g/mol

Ref: 54-BISN0245

SB 203580 hydrochloride

CAS: 869185-85-3

SB 203580 hydrochloride (Adezmapimod hydrochloride) is a p38 MAPK inhibitor that induces mitochondrial autophagy and cytosolic autophagy.

Formel: C₂₁H₁₇ClFN₃OS

Reinheit: 97.79%

Farbe und Form: Solid

Molekulargewicht: 413.9

Ref: TM-T21675

SB 203580 Hydrochloride

Kontrolliertes Produkt

CAS: 869185-85-3

Formel: C₂₁H₁₆FN₃OS·HCl

Farbe und Form: Neat

Molekulargewicht: 377.43 + 36.46

Ref: TR-S155058

SB 203580 hydrochloride

CAS: 869185-85-3

SB 203580 hydrochloride is a p38 MAPK inhibitor that binds to the receptor site of the human serum albumin. It has been shown to have a significant effect on cell proliferation and cell migration in corneal endothelial cells and epidermal growth factor receptor-positive epithelial cells in culture. SB 203580 hydrochloride also inhibits protease activity, which may be related to its ability to inhibit tumor necrosis factor-α (TNF-α) production. SB 203580 hydrochloride is a nanoparticulate composition that can be used for treatment of inflammatory disorders such as asthma, COPD, and rheumatoid arthritis.

Formel: C₂₁H₁₆FN₃OS·HCl

Reinheit: Min. 95%

Molekulargewicht: 413.89 g/mol

Ref: 3D-UJB18585